RecruitingNot ApplicableNCT04728048

Dural Puncture Epidural VS Standard Epidural on Physician Top-ups During Labour Analgesia

A Randomized Clinical Study to Compare the Number of Physician Top-up Interventions During the First Stage of Labour Between Two Different Neuraxial Analgesia Techniques: the Dural Puncture Epidural and the Standard Epidural


Sponsor

Ciusss de L'Est de l'Île de Montréal

Enrollment

130 participants

Start Date

Jan 19, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this prospective randomized controlled study is to compare the number of physician top-up interventions during the first stage of labour between two different neuraxial analgesia techniques : the dural puncture epidural and the standard epidural.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria8

  • Healthy pregnant women (ASA 1 and 2) requesting epidural analgesia during labour.
  • Primiparous and multiparous parturients at term gestation (37 to 42 weeks).
  • Women 18 years old and older.
  • Administration of epidural analgesia between 7am and 4pm on weekdays.
  • Singleton and vertex presentation foetus.
  • Cervical dilatation ≤ 5 cm.
  • BMI ≤ 40.
  • French speaking

Exclusion Criteria6

  • Pregnancy diseases such as gestational hypertension, preeclampsia and gestational diabetes.
  • Contraindications to neuraxial analgesia: thrombocytopenia < 70 x 109/L, spinal cord anomalies, anticoagulation therapy, etc.
  • Known important fetal anomalies.
  • Allergy to any of the medications used in the study.
  • Suspected chorioamnionitis with spontaneous premature rupture of membranes (PROM).
  • Difficulty understanding and speaking French.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREDural puncture epidural

already described

PROCEDUREStandard epidural

already described


Locations(1)

CIUSSS de l'Est de l'Île de Montréal

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04728048


Related Trials